PSP
ABBV icon

Principal Street Partners’s AbbVie ABBV Stock Holding History

Principal Street Partners’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$8.04M Sell
36,983
-598
-2% -$133K 1.31% 18
2025
Q4 		$8.59M Sell
37,581
-1,970
-5% -$449K 1.45% 13
2025
Q3 		$9.16M Sell
39,551
-11,791
-23% -$2.4M 1.46% 12
2025
Q2 		$9.53M Buy
51,342
+12,249
+31% +$2.28M 0.93% 19
2025
Q1 		$8.19M Buy
39,093
+2,080
+6% +$404K 1.52% 12
2024
Q4 		$6.58M Sell
37,013
-4,479
-11% -$823K 1.29% 21
2024
Q3 		$7.93M Sell
41,492
-5,765
-12% -$1.08M 1.3% 11
2024
Q2 		$8.11M Sell
47,257
-84
-0.2% -$13.9K 1.45% 11
2024
Q1 		$8.31M Buy
47,341
+9,037
+24% +$1.56M 1.57% 9
2023
Q4 		$5.94M Sell
38,304
-2,397
-6% -$349K 1.43% 12
2023
Q3 		$6.07M Buy
40,701
+2,967
+8% +$436K 1.2% 11
2023
Q2 		$5.08M Sell
37,734
-1,497
-4% -$220K 1.21% 25
2023
Q1 		$6.25M Buy
39,231
+1,353
+4% +$207K 1.58% 10
2022
Q4 		$6.12M Buy
37,878
+243
+0.6% +$37.3K 1.54% 10
2022
Q3 		$5.05M Sell
37,635
-116
-0.3% -$16.6K 1.35% 18
2022
Q2 		$5.78M Sell
37,751
-10,446
-22% -$1.6M 1.5% 17
2022
Q1 		$7.81M Sell
48,197
-70
-0.1% -$10.2K 1.79% 8
2021
Q4 		$6.54M Buy
48,267
+2,233
+5% +$264K 1.57% 12
2021
Q3 		$4.97M Sell
46,034
-687
-1% -$78.5K 1.35% 23
2021
Q2 		$5.26M Sell
46,721
-66,610
-59% -$7.5M 1.39% 15
2021
Q1 		$12.3M Buy
113,331
+69,351
+158% +$7.42M 1.58% 36
2020
Q4 		$4.71M Sell
43,980
-3,674
-8% -$353K 1.44% 18
2020
Q3 		$4.17M Sell
47,654
-6,633
-12% -$624K 1.47% 25
2020
Q2 		$5.33M Sell
54,287
-25,046
-32% -$2.21M 1.99% 6
2020
Q1 		$6.04M Sell
79,333
-18,831
-19% -$1.6M 2.54% 4
2019
Q4 		$8.69M Buy
98,164
+3,323
+4% +$276K 1.94% 7
2019
Q3 		$7.18M Buy
94,841
+70,440
+289% +$4.83M 1.8% 20
2019
Q2 		$1.77M Sell
24,401
-31,270
-56% -$2.46M 0.98% 32
2019
Q1 		$4.49M Buy
+55,671
New +$4.55M 1.95% 37

Other funds holding ABBV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Principal Street Partners's ABBV Position: Q1 2026 in Review

Principal Street Partners reduced its AbbVie (ABBV) stake by 1.6% in Q1 2026, selling an estimated $133K and leaving 36,983 shares worth $8.04M. The position accounts for 1.31% of the portfolio, ranked #18.

Principal Street Partners first reported a position in ABBV in Q1 2019 and has held it in 29 quarters since. The position peaked at $12.3M in Q1 2021. 4,075 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Principal Street Partners held 36,983 shares of AbbVie worth $8.04M as of Q1 2026.
  • Principal Street Partners sold 598 AbbVie shares in Q1 2026, an estimated $133K.
  • AbbVie made up 1.31% of Principal Street Partners's portfolio in Q1 2026, its #18 holding.
  • Principal Street Partners first reported a position in AbbVie in Q1 2019 and has held it in 29 quarters since.
  • Principal Street Partners's AbbVie position peaked at $12.3M in Q1 2021.
  • 4,075 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Principal Street Partners's 13F filing for Q1 2026, filed 15 May 2026.